Endoscopic Diagnostic and Therapeutic Device Market: Cost, Price, Revenue Analysis Industry Chain Report 2025
On Nov 12, Global Info Research released "Global Endoscopic Diagnostic and Therapeutic Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report includes an overview of the development of the Endoscopic Diagnostic and Therapeutic Device industry chain, the market status of Endoscopic Diagnostic and Therapeutic Device Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Endoscopic Diagnostic and Therapeutic Device.
According to our (Global Info Research) latest study, the global Endoscopic Diagnostic and Therapeutic Device market size was valued at US$ 7480 million in 2024 and is forecast to a readjusted size of USD 11316 million by 2031 with a CAGR of 6.1% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Endoscopic diagnostic and therapeutic devices are specialized medical instruments designed to be used with endoscopes for the visualization, diagnosis, and treatment of conditions within the body’s internal cavities or luminal organs. These devices can include biopsy forceps, snares, injection needles, electrosurgical tools, and other accessories that enable minimally invasive procedures, allowing for tissue sampling, polyp removal, bleeding control, and lesion treatment with reduced patient trauma and faster recovery times.In 2024, global Endoscopic diagnostic and therapeutic devices production reached approximately 550 m units, with an average global market price of around US$ 13.22 perunit.
Population aging and rising GI/respiratory disease burdens, together with government-backed early screening and minimally invasive care, are shifting endoscopy from “diagnostics only” to “diagnostics-to-therapy.” Company annual reports and broker coverage indicate HD/NBI imaging, single-use scopes/consumables, and integrated energy platforms are lifting procedure throughput and bed turnover. Reimbursement expansion and volume-based procurement are catalyzing structural growth and penetration into lower-tier hospitals. Meanwhile, AI quality control and CADx/CADe improve early-cancer detection, and hospitals—via discipline building and day-surgery expansion—treat endoscopic therapy as a high-throughput, cost-effective growth engine.
Tighter regulation, higher standards, and rising compliance costs persist. Although localization of key components (sensors, optics, power/energy control) is progressing, consistency and clinical-evidence depth still require time. Single-use adoption heightens cost sensitivity; without aligned reimbursement and pricing mechanisms, margins can be compressed. Global supply chains face raw-material and logistics volatility, while overseas market access, registration timelines, and academic promotion needs elevate launch uncertainty and lengthen cash cycles.
Clinical demand is moving from “see” to “see clearly, treat effectively, and streamline.” Hospitals prefer end-to-end solutions—imaging, access, energy, and traceable SPD services—with day-surgery pathways driving share gains for single-use and easy-reprocessing products. Advanced procedures (ESD/POEM/ERCP/EMR/bronchial interventions) are scaling, pulling through high-end energy systems and interventional disposables; primary care favors durable, easy-to-maintain devices and standardized kits. Internationally, “premium + localized service” coexists with value-oriented demand in emerging markets, shaping multi-tier, scenario-based procurement logic.
This report is a detailed and comprehensive analysis for global Endoscopic Diagnostic and Therapeutic Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
According to our (Global Info Research) latest study, the global Endoscopic Diagnostic and Therapeutic Device market size was valued at US$ 7480 million in 2024 and is forecast to a readjusted size of USD 11316 million by 2031 with a CAGR of 6.1% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Endoscopic diagnostic and therapeutic devices are specialized medical instruments designed to be used with endoscopes for the visualization, diagnosis, and treatment of conditions within the body’s internal cavities or luminal organs. These devices can include biopsy forceps, snares, injection needles, electrosurgical tools, and other accessories that enable minimally invasive procedures, allowing for tissue sampling, polyp removal, bleeding control, and lesion treatment with reduced patient trauma and faster recovery times.In 2024, global Endoscopic diagnostic and therapeutic devices production reached approximately 550 m units, with an average global market price of around US$ 13.22 perunit.
Population aging and rising GI/respiratory disease burdens, together with government-backed early screening and minimally invasive care, are shifting endoscopy from “diagnostics only” to “diagnostics-to-therapy.” Company annual reports and broker coverage indicate HD/NBI imaging, single-use scopes/consumables, and integrated energy platforms are lifting procedure throughput and bed turnover. Reimbursement expansion and volume-based procurement are catalyzing structural growth and penetration into lower-tier hospitals. Meanwhile, AI quality control and CADx/CADe improve early-cancer detection, and hospitals—via discipline building and day-surgery expansion—treat endoscopic therapy as a high-throughput, cost-effective growth engine.
Tighter regulation, higher standards, and rising compliance costs persist. Although localization of key components (sensors, optics, power/energy control) is progressing, consistency and clinical-evidence depth still require time. Single-use adoption heightens cost sensitivity; without aligned reimbursement and pricing mechanisms, margins can be compressed. Global supply chains face raw-material and logistics volatility, while overseas market access, registration timelines, and academic promotion needs elevate launch uncertainty and lengthen cash cycles.
Clinical demand is moving from “see” to “see clearly, treat effectively, and streamline.” Hospitals prefer end-to-end solutions—imaging, access, energy, and traceable SPD services—with day-surgery pathways driving share gains for single-use and easy-reprocessing products. Advanced procedures (ESD/POEM/ERCP/EMR/bronchial interventions) are scaling, pulling through high-end energy systems and interventional disposables; primary care favors durable, easy-to-maintain devices and standardized kits. Internationally, “premium + localized service” coexists with value-oriented demand in emerging markets, shaping multi-tier, scenario-based procurement logic.
This report is a detailed and comprehensive analysis for global Endoscopic Diagnostic and Therapeutic Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Sample Report Request Endoscopic Diagnostic and Therapeutic Device
https://www.globalinforesearch.com/reports/2944208/endoscopic-diagnostic-and-therapeutic-device
Market segment by Type: Biopsy、 Hemostasis and Closure、 Dilation、 EUS、 EMR/ESD、 ERCP
Market segment by Application: Gastroenterology、 Respiratory、 Other
Major players covered: Olympus、 Boston Scientific、 Cook Medical、 Micro Tech、 CONMED、 Always Good Solutions、 KARL STORZ、 HOYA、 Anrei Medical、 Jiangsu Weidekang、 Changzhou Jiuhong、 Sonoscape、 Aohua Medical
Market segment by region, regional analysis covers: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endoscopic Diagnostic and Therapeutic Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Endoscopic Diagnostic and Therapeutic Device, with price, sales, revenue and global market share of Endoscopic Diagnostic and Therapeutic Device from 2020 to 2025.
Chapter 3, the Endoscopic Diagnostic and Therapeutic Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endoscopic Diagnostic and Therapeutic Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2020 to 2024.and Endoscopic Diagnostic and Therapeutic Device market forecast, by regions, type and application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Endoscopic Diagnostic and Therapeutic Device.
Chapter 14 and 15, to describe Endoscopic Diagnostic and Therapeutic Device sales channel, distributors, customers, research findings and conclusion.
https://www.globalinforesearch.com/reports/2944208/endoscopic-diagnostic-and-therapeutic-device
Market segment by Type: Biopsy、 Hemostasis and Closure、 Dilation、 EUS、 EMR/ESD、 ERCP
Market segment by Application: Gastroenterology、 Respiratory、 Other
Major players covered: Olympus、 Boston Scientific、 Cook Medical、 Micro Tech、 CONMED、 Always Good Solutions、 KARL STORZ、 HOYA、 Anrei Medical、 Jiangsu Weidekang、 Changzhou Jiuhong、 Sonoscape、 Aohua Medical
Market segment by region, regional analysis covers: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endoscopic Diagnostic and Therapeutic Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Endoscopic Diagnostic and Therapeutic Device, with price, sales, revenue and global market share of Endoscopic Diagnostic and Therapeutic Device from 2020 to 2025.
Chapter 3, the Endoscopic Diagnostic and Therapeutic Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endoscopic Diagnostic and Therapeutic Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2020 to 2024.and Endoscopic Diagnostic and Therapeutic Device market forecast, by regions, type and application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Endoscopic Diagnostic and Therapeutic Device.
Chapter 14 and 15, to describe Endoscopic Diagnostic and Therapeutic Device sales channel, distributors, customers, research findings and conclusion.
Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
About Us:
Global Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
